Transcatheter Embolization and Occlusion Devices | Market Insights | US | 2024
The US TEO device market will expand at a moderate rate over the forecast period after recovering from the impact of COVID-19. The market factors contributing to this growth will include the continued adoption of minimally invasive treatments, launch of innovative new products in the liquid embolic and flow-diverting device segments, and expanding treatment indications for existing products.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for TEO devices in the US from 2019 through 2032.